RxDoctor Payments Data

Horacio Alvarez Ramirez, MD

Family Medicine · Lincoln, NENPI 1093155517

Payments from drug & device makers

$3,182in general payments, 2019–2025

Across 84 payments — averaging $37.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$2K
  • Novo Nordisk$385
  • AbbVie$166
  • Otsuka America Pharmaceutical, Inc.$140
  • Pfizer$71
  • Astellas Pharma US Inc$69
  • plus $526 from 18 others

What the payments were for

  • Food & beverage$1,357100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,182 in reported general payments places this provider in the 80th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$815
Medicare patients
23
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$86,359
JardianceEmpagliflozin82$85,358
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$45,514
Combivent RespimatIpratropium/Albuterol Sulfate25$21,983
TrulicityDulaglutide19$20,750
XareltoRivaroxaban13$17,305
Tresiba Flextouch U-100Insulin Degludec14$9,426
Breo ElliptaFluticasone/Vilanterol13$8,255
SymbicortBudesonide/Formoterol Fumarate17$7,150
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro15$4,329
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$4,004
Humalog Kwikpen U-100Insulin Lispro11$3,206
Atorvastatin Calcium319$2,181
Albuterol Sulfate HfaAlbuterol Sulfate86$2,090
Omeprazole100$2,077

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$58$107,342107 claims
Novo NordiskOzempic$385$86,35970 claims
GSKTrelegy Ellipta, Breo Ellipta$42$53,76972 claims
Lilly USA, LLCTrulicity$13$20,75019 claims
Johnson & JohnsonXarelto$48$17,30513 claims
AstraZenecaSymbicort$26$7,15017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 981 family medicine providers in Nebraska.

Other family medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →